These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 9026367)
1. The synergistic effect of fluoxetine on the locomotor hyperactivity induced by MK-801, a non-competitive NMDA receptor antagonist. Maj J; Rogóz Z; Skuza G; Wedzony K J Neural Transm (Vienna); 1996; 103(1-2):131-46. PubMed ID: 9026367 [TBL] [Abstract][Full Text] [Related]
2. The effect of antidepressant drugs on the locomotor hyperactivity induced by MK-801, a non-competitive NMDA receptor antagonist. Maj J; Rogóz Z; Skuza G; Sowińska H Neuropharmacology; 1992 Jul; 31(7):685-91. PubMed ID: 1407405 [TBL] [Abstract][Full Text] [Related]
3. NR2B subunit-specific NMDA antagonist Ro25-6981 inhibits the expression of conditioned fear: a comparison with the NMDA antagonist MK-801 and fluoxetine. Haller J; Nagy R; Toth M; Pelczer KG; Mikics E Behav Pharmacol; 2011 Apr; 22(2):113-21. PubMed ID: 21285873 [TBL] [Abstract][Full Text] [Related]
4. Behavioral evidence for modulation by sigma ligands of (+)MK-801-induced hyperlocomotion in monoamine-depleted mice. Okuyama S; Imagawa Y; Tomisawa K Neuropharmacology; 1996 Apr; 35(4):467-74. PubMed ID: 8793909 [TBL] [Abstract][Full Text] [Related]
6. The effects of combined treatment with MK-801 and antidepressant drugs in the forced swimming test in rats. Maj J; Rogóz Z; Skuza G Pol J Pharmacol Pharm; 1992; 44(3):217-26. PubMed ID: 1470560 [TBL] [Abstract][Full Text] [Related]
7. Locomotor hyperactivity induced by MK-801 in rats. Maj J; Rogóz Z; Skuza G Pol J Pharmacol Pharm; 1991; 43(6):449-58. PubMed ID: 1687944 [TBL] [Abstract][Full Text] [Related]
8. Differential effects of 7-OH-DPAT and apomorphine on hyperactivity induced by MK-801 (dizocilpine) in rats. Clements RL; Greenshaw AJ Neuropharmacology; 2005 Dec; 49(7):1007-16. PubMed ID: 16005475 [TBL] [Abstract][Full Text] [Related]
9. Rodent data and general hypothesis: antipsychotic action exerted through 5-Ht2A receptor antagonism is dependent on increased serotonergic tone. Martin P; Waters N; Schmidt CJ; Carlsson A; Carlsson ML J Neural Transm (Vienna); 1998; 105(4-5):365-96. PubMed ID: 9720968 [TBL] [Abstract][Full Text] [Related]
10. The impact of a competitive and a non-competitive NMDA receptor antagonist on dopaminergic neurotransmission in the rat ventral tegmental area and substantia nigra. Wedzony K; Czyrak A; Maćkowiak M; Fijał K Naunyn Schmiedebergs Arch Pharmacol; 1996 Apr; 353(5):517-27. PubMed ID: 8740145 [TBL] [Abstract][Full Text] [Related]
11. Involvement of N-methyl-D-aspartate (NMDA) receptors in noncompetitive NMDA receptor antagonist-induced hyperlocomotion in mice. Irifune M; Shimizu T; Nomoto M; Fukuda T Pharmacol Biochem Behav; 1995; 51(2-3):291-6. PubMed ID: 7667342 [TBL] [Abstract][Full Text] [Related]
12. MK-801- and ethanol-induced activity in inbred long-sleep and short-sleep mice: dopamine and serotonin systems. Hanania T; McCreary AC; Haughey HM; Salaz DO; Zahniser NR Eur J Pharmacol; 2002 Dec; 457(2-3):125-35. PubMed ID: 12464358 [TBL] [Abstract][Full Text] [Related]
13. Locomotor activation induced by MK-801 in the rat: postsynaptic interactions with dopamine receptors in the ventral striatum. Ouagazzal A; Nieoullon A; Amalric M Eur J Pharmacol; 1994 Jan; 251(2-3):229-36. PubMed ID: 8149978 [TBL] [Abstract][Full Text] [Related]
14. Effects of D1 and D2 dopamine receptor antagonists and catecholamine depleting agents on the locomotor stimulation induced by dizocilpine in mice. Lapin IP; Rogawski MA Behav Brain Res; 1995 Oct; 70(2):145-51. PubMed ID: 8561905 [TBL] [Abstract][Full Text] [Related]
15. Mechanism of synergistic action following co-treatment with pramipexole and fluoxetine or sertraline in the forced swimming test in rats. Rogóz Z; Skuza G Pharmacol Rep; 2006; 58(4):493-500. PubMed ID: 16963794 [TBL] [Abstract][Full Text] [Related]
16. The effect of the NMDA receptor antagonist dizocilpine on behavioral manifestations of serotonin and adrenergic antidepressants in rats. Pruus K; Rudissaar R; Allikmets L; Harro J Methods Find Exp Clin Pharmacol; 2010 Mar; 32(2):123-8. PubMed ID: 20401349 [TBL] [Abstract][Full Text] [Related]
17. Valproate blocks high-dose methamphetamine-induced behavioral cross-sensitization to locomotion-inducing effect of dizocilpine (MK-801), but not methamphetamine. Ito K; Abekawa T; Koyama T Psychopharmacology (Berl); 2006 Jul; 186(4):525-33. PubMed ID: 16758239 [TBL] [Abstract][Full Text] [Related]
18. The dopamine D3 receptor mediates locomotor hyperactivity induced by NMDA receptor blockade. Leriche L; Schwartz JC; Sokoloff P Neuropharmacology; 2003 Aug; 45(2):174-81. PubMed ID: 12842123 [TBL] [Abstract][Full Text] [Related]
19. Non-NMDA excitatory amino acid receptors in the ventral tegmental area mediate systemic dizocilpine (MK-801) induced hyperlocomotion and dopamine release in the nucleus accumbens. Mathé JM; Nomikos GG; Schilström B; Svensson TH J Neurosci Res; 1998 Mar; 51(5):583-92. PubMed ID: 9512002 [TBL] [Abstract][Full Text] [Related]
20. Clozapine does not require 5-HT1A receptors to block the locomotor hyperactivity induced by MK-801 Clz and MK-801 in KO1A mice. Scorza MC; Castañé A; Bortolozzi A; Artigas F Neuropharmacology; 2010; 59(1-2):112-20. PubMed ID: 20412811 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]